Cole-Parmer Acquires ZeptoMetrix

Zeptometrix

Cole-Parmer expands quality control and references portfolio

ZeptoMetrix is a life sciences developer and manufacturer of quality control standards and verification panels used in molecular diagnostic testing for infectious diseases.

Founded in 1999 and headquartered in Buffalo, NY, ZeptoMetrix’s products, including its patented NATtrol™ family of products, are used for nucleic acid testing within the diagnostic testing industry. These products are used regularly by clinical testing labs to verify that molecular diagnostic instruments are performing and accurately detecting the presence of specific genetic material within a patient sample. The ZeptoMetrix product portfolio is focused on infectious disease, including gastrointestinal, women’s health, hospital acquired infections, and respiratory, including the flu, RSV and coronavirus, among others.

Cole-Parmer expands quality control and reference standards

The acquisition of ZeptoMetrix expands Cole-Parmer’s quality controls and reference standards portfolio and further establishes Cole-Parmer as a leading manufacturer of specialty chemistries and reagents for life sciences research and diagnostic testing. The acquisition represents Cole-Parmer’s second acquisition in the past year and 12th since 2014.

“The addition of ZeptoMetrix is highly complementary to our existing product portfolio within the life sciences market,” said Bernd Brust, Chief Executive Officer, Cole-Parmer. “The acquisition underscores our dedication to serving our customers with unique, differentiated products that help accelerate their research & development programs and support their diagnostic workflows.”

“Adding ZeptoMetrix to our global commercial infrastructure enhances our shared ability to continue to support our customers in mission critical applications within the life sciences,” added Jon Salkin, President of Cole-Parmer. “We look forward to continuing to support the ZeptoMetrix customer base and expanding our quality controls and reference standards portfolio via continued investment in organic product development and M&A.”

“As we head into 2021 and continue to respond to the COVID-19 pandemic, the team at ZeptoMetrix are excited to become part of Cole-Parmer and the wealth of additional capabilities to serve and support our customers that this acquisition provides,” said Shawn Smith, General Manager, ZeptoMetrix. “In an instant, we have gained strength in both technical aptitude and commercial presence, both of which will complement our ongoing efforts to continuously improve upon how we facilitate the success of our customers. As we embark on a new corporate structure, we commit to keeping our customers as the top priority they have always been — and now we can do so with a depth of resources previously unavailable to ZeptoMetrix.”

About Cole-Parmer

Cole-Parmer is a leading global manufacturer of proprietary products for fluidics, environmental, analytics, lab essentials, and critical research and process equipment for life sciences. We are proven experts in the fields of fluid handling, environmental testing, cold chain monitoring, sample preparation and handling, and chromatography. Our instruments and components are used extensively in the biopharma, pharmaceutical, life sciences, environmental, and the food and beverage industries.

Our portfolio of unique industry-leading brands includes Masterflex®, Environmental Express®, Ismatec®, Oakton®, PCRmax®, SPEX®, Traceable®, and more. We also partner with a select set of key suppliers with trusted products. Cole-Parmer is also globally renowned for exceptional customer service and expert technical support including pipette services, calibration and instrument service capabilities.

About ZeptoMetrix

ZeptoMetrix Corporation is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Founded in 1999, the company’s expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and made ZeptoMetrix the preferred choice for independent 3rd party quality control materials. ZeptoMetrix’s patented NATtrolTM process renders highly purified non-infectious while allowing internal nucleic acids to remain intact, thereby serving as an ideal reference material for molecular diagnostic testing applications. Representing a total process control, from DNA extraction through amplification and eventual detection, NATtrolTM products are ready-to-use, refrigerator stable, and safe for operators to handle. For more information, please visit www.zeptometrix.com. 

 

 

Be the first to comment on "Cole-Parmer Acquires ZeptoMetrix"

Leave a comment

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: